Cargando…
Heparanase-2 protein and peptides have a protective effect on experimental glomerulonephritis and diabetic nephropathy
Introduction: The endothelial glycocalyx degrading enzyme heparanase-1 (HPSE1) is a major contributor to kidney diseases, such as glomerulonephritis and diabetic nephropathy. Therefore, inhibition of HPSE1 could be an interesting therapeutic strategy to treat glomerular diseases. A possible HPSE1 in...
Autores principales: | Buijsers, Baranca, Garsen, Marjolein, de Graaf, Mark, Bakker-van Bebber, Marinka, Guo, Chunming, Li, Xue, van der Vlag, Johan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172501/ https://www.ncbi.nlm.nih.gov/pubmed/37180718 http://dx.doi.org/10.3389/fphar.2023.1098184 |
Ejemplares similares
-
Glycosaminoglycans and fucoidan have a protective effect on experimental glomerulonephritis
por: Buijsers, Baranca, et al.
Publicado: (2023) -
Heparanase Is Essential for the Development of Diabetic Nephropathy in Mice
por: Gil, Natali, et al.
Publicado: (2012) -
Peroxisome proliferator-activated receptor ɣ agonist mediated inhibition of heparanase expression reduces proteinuria
por: Garsen, Marjolein, et al.
Publicado: (2023) -
Heparanase Is a Putative Mediator of Endothelial Glycocalyx Damage in COVID-19 – A Proof-of-Concept Study
por: Drost, Carolin Christina, et al.
Publicado: (2022) -
Endothelial Nitric Oxide Synthase Prevents Heparanase Induction and the Development of Proteinuria
por: Garsen, Marjolein, et al.
Publicado: (2016)